EP Patent

EP3597646A1 — Therapeutic compounds useful for the prophylactic or therapeutic treatment of an hiv virus infection

Assigned to Gilead Sciences Inc · Expires 2020-01-22 · 6y expired

What this patent protects

The present disclosure relates to a compound of formula (la), (lb), (IIa), and (IIb):which are useful in the treatment ofa Retroviridaeviral infection including an infection caused by the HIV virus.

USPTO Abstract

The present disclosure relates to a compound of formula (la), (lb), (IIa), and (IIb):which are useful in the treatment ofa Retroviridaeviral infection including an infection caused by the HIV virus.

Drugs covered by this patent

Patent Metadata

Patent number
EP3597646A1
Jurisdiction
EP
Classification
—
Expires
2020-01-22
Drug substance claim
No
Drug product claim
No
Assignee
Gilead Sciences Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.